Leiomyoma Cutis: A Focused Review on Presentation, Management, and Association with Malignancy
Authors:
- 22 January 2015
- journal article
- review article
- Published by Springer Nature in American Journal of Clinical Dermatology
- Vol. 16 (1) , 35-46
Abstract
Cutaneous leiomyomas (CLs) are rare, sporadic, or inherited tumors of smooth muscle origin associated with various disorders. Hereditary leiomyomatosis and renal cell cancer (HLRCC) is the primary tumor predisposition syndrome associated with inherited CLs, affecting 180 families worldwide, with significant mortality. CLs are subdivided into piloleiomyomas, genital leiomyomas, and angioleiomyomas based on their smooth muscle of origin, as well as their clinicopathologic features. Piloleiomyomas, derived from arrector pili muscle, are solitary or multiple firm papulonodules located typically on the extremities and trunk; genital leiomyomas, derived from dartoic, vulvar, or mammary smooth muscle, are solitary papulonodules or pedunculated papules located on the scrotum, vulva, or nipple; and angioleiomyomas, which include solid, cavernous, or venous subtypes, are derived from the tunica media of small arteries and veins and typically present on the extremities. Partial/excisional biopsy is required for diagnosing all CLs. Histology shows interlacing fascicles of spindle cells with moderate amounts of eosinophilic cytoplasm and a blunt-ended, elongated nucleus with perinuclear halos. Surgical excision is curative for CLs, with other management options including medical or destructive therapy; active surveillance is advised to monitor HLRCC-associated neoplasms, with pharmacological therapies under active research.Keywords
This publication has 104 references indexed in Scilit:
- Renal cancer-selective Englerin A induces multiple mechanisms of cell death and autophagyJournal of Experimental & Clinical Cancer Research, 2013
- Hereditary leiomyomatosis and renal cell cancer presenting as metastatic kidney cancer at 18 years of age: implications for surveillanceFamilial Cancer, 2011
- The Glycolytic Shift in Fumarate-Hydratase-Deficient Kidney Cancer Lowers AMPK Levels, Increases Anabolic Propensities and Lowers Cellular Iron LevelsCancer Cell, 2011
- The genetic basis of kidney cancer: a metabolic diseaseNature Reviews Urology, 2010
- Fumarate Hydratase Deficiency in Renal Cancer Induces Glycolytic Addiction and Hypoxia-Inducible Transcription Factor 1α Stabilization by Glucose-Dependent Generation of Reactive Oxygen SpeciesMolecular and Cellular Biology, 2009
- Regulation of cancer cell metabolism by hypoxia-inducible factor 1Seminars in Cancer Biology, 2009
- Association of Germline Mutations in the Fumarate Hydratase Gene and Uterine Fibroids in Women With Hereditary Leiomyomatosis and Renal Cell CancerArchives of Dermatology, 2008
- The FH mutation database: an online database of fumarate hydratase mutations involved in the MCUL (HLRCC) tumor syndrome and congenital fumarase deficiencyBMC Medical Genetics, 2008
- HIF and fumarate hydratase in renal cancerBritish Journal of Cancer, 2007
- The Relation Between Histological, Tumor‐Biological and ClinicalParameters in Deep and Superficial Leiomyosarcoma and LeiomyomaSarcoma, 2002